跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 410 条关于
“inorganic pyrophosphate”
全部
410
临床试验
322
药物
32
机构
6
资讯
50
上个月
BioMarin to Acquire Alesta Therapeutics for ALE1, a Potential First Oral Therapy for Hypophosphatasia
4个月前
BioMarin's BMN 401 Shows Mixed Results in Phase 3 Trial for Rare ENPP1 Deficiency
上个月
BioMarin acquires Alesta Therapeutics and its hypophosphatasia drug ALE1 in $275M deal
去年
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
去年
Be Biopharma to Present Promising Nonclinical Data for Novel B Cell Therapy in Hypophosphatasia Treatment
去年
PROPHECI Trial Launches to Test Pyrophosphate Treatment for Rare Calcification Disorder PXE
2个月前
Consumer Reports Investigation Finds Concerning Arsenic Levels Across All 52 Rice Products Tested
去年
BioMarin Acquires Inozyme Pharma for $270 Million, Adding Late-Stage Enzyme Therapy for Rare Genetic Disorder
10天前
Scientists Map the Enzymatic Route That Builds 5-Azacytidine in Nature, Revealing a Rare Skeletal-Editing Reaction
11个月前
UNC Scientists Engineer DNA Flower Robots for Targeted Drug Delivery
第 1 页,共 5 页
上一页
下一页